NOVEL BIOMARKER FOR DETERMINING DISEASE ACTIVITY OR PROGNOSIS OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Discriminating Parkinson's Disease from Multiple System Atrophy Using Alpha- Synuclein PMCA

METHODS OF TREATING MUSCULAR DYSTROPHY

Discriminating Parkinson's Disease from Multiple System Atrophy Using Alpha-Synuclein PMCA

DIAGNOSTIC BIOMARKERS FOR LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2H AND USE THEREOF

COMPOSITIONS AND METHODS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY BIOMARKER DETECTION

CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS

METHODS FOR ASSAYING SLC34A2 EXPRESSION IN MUSCLE TISSUE AND TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

CIRCULATING miRNA AND PROTEIN BIOMARKERS FOR FACIOSCAPULOHUMERAL DYSTROPHY

Anti-TDP-43 Binding Molecules and Uses Thereof

Compositions and methods for detection of SMN protein in a subject and treatment of a subject

COMPOSITIONS FOR THE TREATMENT OF SARCOPENIA OR DISUSE ATROPHY

METHOD FOR ANALYZING EXPRESSION OF SMN PROTEIN NUCLEAR BODY

METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)

Discriminating Parkinson's disease from multiple system atrophy using alpha-synuclein PMCA

Compositions and methods for modulating dysferlin expression

METHOD AND KIT FOR DIAGNOSIS OF MUSCLE WEAKNESS-RELATED DISEASES USING BLOOD BIOMARKER

Amyotrophic lateral sclerosis diagnostic composition using acid sphingomyelinase, and method for detecting diagnostic markers

USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING

Disease prevention and alleviation by human myoblast transplantation

Methods for treating spinal muscular atrophy

METHODS FOR DIAGNOSING, PROGNOSING AND TREATING MUSCULAR DYSTROPHY

Method for Detecting SMN Protein Expression

Compositions and methods for modulating dysferlin expression

Method for treating muscular dystrophy

Methods for diagnosing or monitoring muscular dystrophies

Compositions and methods for treatment of muscular dystrophy

Methods for the diagnosis of amyotrophic lateral sclerosis

Nucleic acids encoding FHL1 mutations associated with novel X-linked muscular myopathies and methods of screening a subject

Synthetic analogues of neural regeneration peptides

Method for diagnosing muscular dystrophy

Methods for diagnosing, prognosing and treating muscular dystrophy

Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder

Compositions and methods related to protein displacement therapy for myotonic distrophy

Theranostics platform and methods of use

Use of RANK/RANKL antagonists for treating muscular dystrophy

Methods of identifying FHL1 mutations associated with novel X-linked muscular myopathies

Therapeutic and diagnostic methods involving biglycan and utrophin

Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL

Synthetic analogues of neural regeneration peptides

Methods for treating muscular dystrophy

MOLECULAR MARKER FOR EVALUATING PATHOLOGICAL CONDITIONS AND TREATMENT OF MUSCULAR DYSTROPHY

Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation

Biglycan and related therapeutics and methods of use

Method of regulating the expression level of survival of motor neuron 1

MITOCHONDRIAL INHIBITORS AND USES THEREOF

Treatment for spinal muscular atrophy

Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases

METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCULAR DYSTROPHY

Biglycan and related therapeutics and methods of use

Synthetic analogues of neural regeneration peptides

METHODS OF IDENTIFYING HISTONE DEACETYLASE INHIBITORS USEFUL FOR NEUROLOGICAL DISORDERS

Methods of screening a subject for mutations associated with novel X-linked muscular myopathies

COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY

Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress

TREATMENT FOR SPINAL MUSCULAR ATROPHY

Biglycan and related therapeutics and methods of use

METHODS OF DIAGNOSIS AND PROGNOSIS FOR A MUSCULAR DYSTROPHY

DNA encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity

Biglycan and related therapeutics and methods of use

Treatment for spinal muscular atrophy

Methods for identifying compounds for regulating muscle mass or function using dopamine receptors

Assay methods and amelioration of muscular dystrophy symptoms

Biglycan and related therapeutics and methods of use

Methods of detecting and treating facioscapulohumeral muscular dystrophy